PROTEUS: A Practice-changing Trial, but Are We Ready to Embrace Perioperative Apalutamide for All High-risk Patients?

Giuseppe Di Lorenzo1, Francesco Montorsi2

  • 1Oncology Unit, "Andrea Tortora" Hospital, ASL Salerno, Pagani, Italy; UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy.

Abstract

No abstract available in PubMed .